Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to NON-SMALL CELL LUNG CANCER (NSCLC)

Journal of Clinical Oncology

Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non–Small-Cell Lung Cancer Previously Treated With Immunotherapy—Lung-MAP S1800A

Oncology, Medical June 27th 2022

ReachMD

CME: Practicing Precision in ALK and ROS1 Rearrangement Positive Non-Small Cell Lung Cancer (NSCLC): Testing, Targets, and Treatments

Oncology, Medical May 25th 2022

Cancer Therapy Advisor

Sintilimab Provides ‘Robust’ Survival Benefit in Advanced Non-Small Cell Lung Cancer (NSCLC)

Oncology, Medical May 25th 2022

Cancer Therapy Advisor

Neoadjuvant Nivolumab Plus Chemo Deemed New Standard Care for Resectable Non-Small Cell Lung Cancer (NSCLC)

Oncology, Medical May 25th 2022

OBR Oncology

Roche Cancer Immunotherapy Fails Another Trial, Casting Doubt On Emerging Drug Class

Oncology, Medical May 25th 2022

Journal of Clinical Oncology

COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination with Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non–Small-Cell Lung Cancer (NSCLC)

Oncology, Medical May 25th 2022